Total Payments
$4,532
2024 Payments
$1,543
Companies
17
Transactions
186
Medicare Patients
11,163
Medicare Billing
$913,604
Payment Breakdown by Category
Food & Beverage$4,197 (92.6%)
Education$335.38 (7.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,197 | 181 | 92.6% |
| Education | $335.38 | 5 | 7.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $906.54 | 43 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $685.39 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $560.23 | 20 | $0 (2024) |
| Janssen Biotech, Inc. | $465.20 | 23 | $0 (2024) |
| Lilly USA, LLC | $420.70 | 12 | $0 (2024) |
| GENZYME CORPORATION | $300.20 | 11 | $0 (2024) |
| LEO Pharma Inc. | $239.27 | 11 | $0 (2024) |
| PFIZER INC. | $132.72 | 6 | $0 (2024) |
| Genentech USA, Inc. | $131.55 | 2 | $0 (2020) |
| Arcutis Biotherapeutics, Inc. | $119.74 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,543 | 68 | ABBVIE INC. ($380.65) |
| 2023 | $1,666 | 69 | Sun Pharmaceutical Industries Inc. ($326.40) |
| 2022 | $730.37 | 34 | ABBVIE INC. ($343.10) |
| 2021 | $28.62 | 2 | Novartis Pharmaceuticals Corporation ($14.86) |
| 2020 | $53.08 | 3 | PFIZER INC. ($26.35) |
| 2018 | $226.38 | 4 | Novartis Pharmaceuticals Corporation ($119.35) |
| 2017 | $284.02 | 6 | Genentech USA, Inc. ($118.75) |
All Payment Transactions
186 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: Immunology | ||||||
| 12/09/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: Immunology | ||||||
| 12/03/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.44 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: Immunology | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.56 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: DERMATOLOGY | ||||||
| 07/25/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Immunology | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $32.94 | General |
| 07/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Dermatology | ||||||
| 07/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Dermatology | ||||||
| 07/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,134 | 6,985 | $830,647 | $249,662 |
| 2022 | 24 | 2,979 | 6,587 | $822,629 | $254,737 |
| 2021 | 23 | 2,897 | 6,447 | $796,958 | $257,110 |
| 2020 | 18 | 2,153 | 4,324 | $499,357 | $152,095 |
Total Patients
11,163
Total Services
24,343
Medicare Billing
$913,604
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 660 | 968 | $181,829 | $56,652 | 31.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 364 | 460 | $98,578 | $28,759 | 29.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 261 | 327 | $77,035 | $26,943 | 35.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 526 | 748 | $119,037 | $26,529 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 265 | $70,623 | $22,739 | 32.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 73 | 80 | $51,504 | $17,156 | 33.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 434 | 3,333 | $49,395 | $16,931 | 34.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 91 | 118 | $41,367 | $14,128 | 34.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 124 | 205 | $22,978 | $8,014 | 34.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 56 | 63 | $33,171 | $6,419 | 19.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 103 | 121 | $13,942 | $4,913 | 35.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 34 | 36 | $13,335 | $4,615 | 34.6% |
| 12034 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | Office | 2023 | 11 | 11 | $7,729 | $2,976 | 38.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $9,038 | $2,460 | 27.2% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 22 | 24 | $7,372 | $2,328 | 31.6% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 19 | 19 | $11,421 | $2,141 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,889 | $1,585 | 26.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 33 | 40 | $4,720 | $1,287 | 27.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 14 | 14 | $3,767 | $1,168 | 31.0% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 14 | 16 | $4,470 | $1,125 | 25.2% |
| 69100 | Biopsy of ear | Office | 2023 | 14 | 15 | $3,210 | $742.48 | 23.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 38 | 66 | $236.28 | $50.50 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 616 | 942 | $176,945 | $57,802 | 32.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 325 | 435 | $93,221 | $28,672 | 30.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 262 | 329 | $77,506 | $27,202 | 35.1% |
About Dr. Katherine Manno, MD
Dr. Katherine Manno, MD is a Dermatology healthcare provider based in Reno, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2013. The National Provider Identifier (NPI) number assigned to this provider is 1225474224.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katherine Manno, MD has received a total of $4,532 in payments from pharmaceutical and medical device companies, with $1,543 received in 2024. These payments were reported across 186 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($4,197).
As a Medicare-enrolled provider, Manno has provided services to 11,163 Medicare beneficiaries, totaling 24,343 services with total Medicare billing of $913,604. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Reno, NV
- Active Since 05/16/2013
- Last Updated 07/21/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1225474224
Products in Payments
- SKYRIZI (Biological) $517.06
- TREMFYA (Drug) $442.08
- DUPIXENT (Biological) $357.71
- RINVOQ (Biological) $313.93
- ILUMYA (Biological) $313.26
- OLUMIANT (Drug) $251.59
- COSENTYX (Drug) $248.69
- COSENTYX (Biological) $247.94
- ADBRY (Biological) $211.66
- Winlevi (Drug) $177.09
- TALTZ (Drug) $169.11
- EUCRISA (Drug) $132.72
- Erivedge (Biological) $131.55
- VTAMA (Drug) $113.26
- Sotyktu (Drug) $109.12
- BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 (Device) $107.03
- JUBLIA (Drug) $82.23
- Enbrel (Biological) $63.93
- Zoryve (Drug) $58.72
- HUMIRA (Biological) $52.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Reno
Laura Ostezan, M.d, M.D
Dermatology — Payments: $27,692
Dermatology $27,692
Laura Biehle, Pa-C, PA-C
Dermatology — Payments: $25,736
Dermatology $25,736
Dr. William Mortensen, M.d, M.D
Dermatology — Payments: $12,827
Dermatology $12,827
Mrs. Diane Smith, Aprn, APRN
Dermatology — Payments: $11,999
Dermatology $11,999
Mrs. Cindy Lamerson, Md, MD
Dermatology — Payments: $8,873
Dermatology $8,873
Dr. Gretchen Korver, M.d, M.D
Dermatology — Payments: $8,444
Dermatology $8,444